ERX Eirx Therap.

RNS Number:4445Q
EiRx Therapeutics PLC
31 January 2007


                     EiRx Therapeutics plc (the "Company")

                              Total Voting Rights


In conformity with the Transparency Directive's transitional provision 6, the
Company notifies the market of the following:


As at the date of this announcement, the Company's issued share capital consists
of  2,975,743,260 ordinary shares with a nominal value of 0.2p each ('Ordinary
Shares'), with voting rights. The Company does not hold any Ordinary Shares in
Treasury.


Therefore, the total number of Ordinary Shares with voting rights is
2,975,743,260.


The above figure of  2,975,743,260 Ordinary Shares may be used by shareholders
in the Company as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FSA's Disclosure and
Transparency Rules.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TVREAFFFDFNXEFE

Eirx Therapeutics (LSE:ERX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Eirx Therapeutics (LSE:ERX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024